Phase 3 Results

TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...

TOKYO, Japan and CAMBRIDGE, United Kingdom | January 19, 2026 — Nxera Pharma Co., Ltd. announced positive top-line results...